Genetic variation in the genome-wide predicted estrogen response element-related sequences is associated with breast cancer development

IntroductionEstrogen forms a complex with the estrogen receptor (ER) that binds to estrogen response elements (EREs) in the promoter region of estrogen-responsive genes, regulates their transcription, and consequently mediates physiological or tumorigenic effects. Thus, sequence variants in EREs have the potential to affect the estrogen-ER-ERE interaction. In this study, we examined the hypothesis that genetic variations of EREs are associated with breast cancer development.MethodsThis case-control study involved 815 patients of Asian descent with incident breast cancer and 821 healthy female controls. A total of 13,737 ERE sites in the whole genome predicted by a genome-wide computational algorithm were blasted with single-nucleotide polymorphism (SNP) sequences. Twenty-one SNPs located within 2,000 bp upstream or within introns 1 and 2 of putative genes and with a minor allele frequency greater than 5% were identified and genotyped. Frequencies of SNPs were compared between cases and controls to identify SNPs associated with cancer susceptibility.ResultsA significant combined effect of rs12539530, an ERE SNP in intron 2 of NRCAM which codes for a cell adhesion molecule, and SNPs of ESR1, the gene coding for ER, on breast cancer risk was found. Interestingly, this combined effect was more significant in women who had experienced a longer period of lifetime estrogen exposure, supporting a hormonal etiology of this SNP in breast tumorigenesis.ConclusionsOur findings provide support for a role of genetic variation in ERE-ESR1 in determining susceptibility of breast cancer development.

[1]  Mathieu Blanchette,et al.  PReMod: a database of genome-wide mammalian cis-regulatory module predictions , 2006, Nucleic Acids Res..

[2]  John H. White,et al.  Genome-wide identification of high-affinity estrogen response elements in human and mouse. , 2004, Molecular endocrinology.

[3]  H. Stunnenberg,et al.  ChIP‐Seq of ERα and RNA polymerase II defines genes differentially responding to ligands , 2009, The EMBO journal.

[4]  Y. Shang.  Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis , 2006, Nature Reviews Cancer.

[5]  Marc E. Lippman,et al.  GREB1 is a critical regulator of hormone dependent breast cancer growth , 2005, Breast Cancer Research and Treatment.

[6]  Rachel Schiff,et al.  Estrogen-receptor biology: continuing progress and therapeutic implications. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  H. Stunnenberg,et al.  Identifying estrogen receptor target genes , 2007, Molecular oncology.

[8]  Chiun-Sheng Huang,et al.  Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset) , 1998, International journal of cancer.

[9]  P. Carroll,et al.  A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. , 2000, Cancer research.

[10]  F. Stossi,et al.  Whole-Genome Cartography of Estrogen Receptor α Binding Sites , 2007, PLoS genetics.

[11]  F. Robert,et al.  Genome-wide computational prediction of transcriptional regulatory modules reveals new insights into human gene expression , 2006 .

[12]  Douglas F Easton,et al.  Genome-wide association studies in common cancers--what have we learnt? , 2010, Current opinion in genetics & development.

[13]  A. Levine,et al.  A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans , 2004, Cell.

[14]  Gerhart U. Ryffel,et al.  An estrogen-responsive element derived from the 5′ flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells , 1986, Cell.

[15]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[16]  J. Yager,et al.  Estrogen carcinogenesis in breast cancer. , 2006, The New England journal of medicine.

[17]  Myles A Brown,et al.  Estrogen receptor target gene: an evolving concept. , 2006, Molecular endocrinology.

[18]  C. Yue,et al.  Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis. , 2000, Cancer research.

[19]  Chen-Yang Shen,et al.  Diverse Associations between ESR1 Polymorphism and Breast Cancer Development and Progression , 2010, Clinical Cancer Research.

[20]  H. Ford,et al.  Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression , 2010, Journal of Mammary Gland Biology and Neoplasia.

[21]  Chen-Yang Shen,et al.  Breast cancer risk associated with genotype polymorphism of the catechol estrogen‐metabolizing genes: A multigenic study on cancer susceptibility , 2005, International journal of cancer.

[22]  Chen-Yang Shen,et al.  Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes. , 2009, Carcinogenesis.

[23]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[24]  Vladimir B. Bajic,et al.  Dragon ERE Finder version 2: a tool for accurate detection and analysis of estrogen response elements in vertebrate genomes , 2003, Nucleic Acids Res..

[25]  H. Stunnenberg,et al.  Genomic actions of estrogen receptor alpha: what are the targets and how are they regulated? , 2009, Endocrine-related cancer.

[26]  Giu-Cheng Hsu,et al.  Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility. , 2009, Carcinogenesis.

[27]  J. Carroll,et al.  Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state , 2007, Nature Reviews Cancer.

[28]  Montserrat Garcia-Closas,et al.  Genetic susceptibility to breast cancer , 2010, Molecular oncology.

[29]  Chen-Yang Shen,et al.  Genetic Variation in the Premature Aging Gene WRN: A Case-Control Study on Breast Cancer Susceptibility , 2007, Cancer Epidemiology Biomarkers & Prevention.

[30]  Simak Ali,et al.  Endocrine-responsive breast cancer and strategies for combating resistance , 2002, Nature Reviews Cancer.